Wells Fargo Upgrades Edwards Lifesciences (EW) to Overweight, 'We believe that asymptomatic AS is now a free call option'
Wells Fargo analyst Lawrence Biegelsen upgraded Edwards Lifesciences (NYSE: EW) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)